We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current PROF market cap is 271.26M. The company's latest EPS is USD -1.22 and P/E is -5.62.
| Quarter End | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.62M | 2.21M | 5.29M | 5.98M | 5.34M |
| Operating Income | -11.17M | -13.81M | -8.91M | -7.37M | -8.02M |
| Net Income | -10.72M | -15.7M | -7.98M | -8.18M | -7.05M |
| Year End December 31 2025 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 6.87M | 6.68M | 7.2M | 10.68M | 16.1M |
| Operating Income | -30.29M | -29.6M | -28.65M | -33.06M | -41.25M |
| Net Income | -30.7M | -28.67M | -28.32M | -27.82M | -42.57M |
| Quarter End | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 60.86M | 49.67M | 42.31M | 77.48M | 73.46M |
| Total Liabilities | 10.07M | 10.41M | 10.16M | 11.04M | 14.03M |
| Total Equity | 50.79M | 39.26M | 32.14M | 66.43M | 59.42M |
| Year End December 31 2025 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 86.78M | 64.42M | 43.96M | 70.23M | 77.48M |
| Total Liabilities | 6.16M | 12.42M | 12.73M | 9.81M | 11.04M |
| Total Equity | 80.62M | 52M | 31.22M | 60.42M | 66.43M |
| Quarter End | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -8.28M | -13.74M | -9.61M | -6.57M | -8.58M |
| Investing | N/A | N/A | N/A | -242k | N/A |
| Financing | -290k | N/A | N/A | 41.43M | N/A |
| Year End December 31 2025 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -22.36M | -25.8M | -22.61M | -23.45M | -38.21M |
| Investing | -593k | N/A | N/A | N/A | -242k |
| Financing | 5.95M | 7.03M | 1.76M | 54.7M | 41.14M |
| Market Cap | 271.26M |
| Price to Earnings Ratio | -5.62 |
| Price to Sales Ratio | 13.27 |
| Price to Cash Ratio | 1.38 |
| Price to Book Ratio | 4.20 |
| Dividend Yield (LTM) | N/A |
| Shares Outstanding | 36.34M |
| Average Volume (1 week) | 119.03k |
| Average Volume (1 Month) | 66.97k |
| 52 Week Change | 22.98% |
| 52 Week High | 8.95 |
| 52 Week Low | 3.76 |
| Spread (Intraday) | 0.07 (0.93%) |
| Company Name | Profound Medical Corporation |
| Address |
2400 Skymark Avenue Mississauga, Ontario L4W 5K5 |
| Website | https://www.profoundmedical.com |
| Industry | Medical Equipment & Supplies |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Register with Email
Already have an account? Sign in
Don't have an account? Sign up
By registering, I confirm I have read, understand, and agree to ADVFN's Terms and Conditions and that I am a private investor.
Hot Features
Premium
